Amylin Receptor

胰淀素受体 (AMYR) 是 G 蛋白偶联受体 (GPCR),对肽激素胰淀素和降钙素有反应。胰淀素最初被发现是 2 型糖尿病患者胰岛淀粉样蛋白沉积的主要成分,在糖尿病猫中,胰淀素也是一种生理相关的循环肽激素。胰淀素受体是异二聚体,由降钙素受体组成,降钙素受体是一种 G 蛋白偶联受体,也是三种受体修饰蛋白之一。功能研究的一个障碍是很难将胰淀素受体表型与降钙素受体表型区分开来。胰淀素受体是治疗肥胖症和代谢紊乱的靶点。

Amylin receptors (AMYRs) are G protein-coupled receptors (GPCRs), which respond to the peptide hormones amylin and calcitonin. Amylin was originally discovered as the main constituent of pancreatic islet amyloid deposits in type 2 diabetics and in diabetic cats, amylin is also a physiologically relevant circulating peptide hormone. Amylin receptors are heterodimers comprising the calcitonin receptor, which is a G protein–coupled receptor, and one of three receptor-modifying proteins. An impediment to functional studies is that it is difficult to separate amylin receptor phenotypes from calcitonin receptor phenotypes. Amylin receptors are targets for treating obesity and metabolic disorders.

共 3种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
(R)-CTR/AMYR activator-1

(R)-CTR/AMYR activator-1(Compound 122)是一种 CTR/AMYR 激动剂,其 EC50 值分别为 0.8 和 0.73 nM,可用于骨骼疾病、代谢性疾病、心血管疾病以及神经退行性疾病的相关研究。

3068778-30-0
Activator
(R)-CTR/AMYR activator-1
CTR/AMYR activator-1

CTR/AMYR activator-1(化合物122的S构型)是一种CTR/AMYR激活剂,可用于骨骼疾病、代谢疾病、心血管疾病和神经退行性疾病的研究。

3068779-36-9
Activator
CTR/AMYR activator-1
KBP-042

KBP-042 是一种口服有效的胰淀素受体激活剂,同时也是降钙素受体激活剂,可诱导持续性体重减轻、减少脂肪组织量、降低肝脏脂质沉积、提高血浆脂联素水平、降低血浆瘦素水平并降低血浆葡萄糖依赖性促胰岛素多肽水平,可用于肥胖和胰岛素抵抗的相关研究。

Activator
KBP-042

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础